Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
Navneet S. Majhail(Sarah Cannon), André Tichelli(University Hospital of Basel), Carmem Bonfim(Universidade Federal do Paraná), Gèrard Socié(Hôpital Saint-Louis), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jeff Szer(The Royal Melbourne Hospital), Shinichiro Okamoto(Keio University), Yoshiko Atsuta(The Japanese Data Center for Hematopoietic Cell Transplantation), Adriana Seber(Support group for adolescents and children with cancer), J. Douglas Rizzo, Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Linda J. Burns(University of Minnesota System), John R. Wingard(University of Florida Health), Maria Teresa Van Lint(Ospedale Policlinico San Martino), Naeem Chaudhri(King Faisal Specialist Hospital & Research Centre)
Cited by 363
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k